Benzinga | Sep 1, 2020 08:12AM EDT

CHF Solutions Receives 180-Day Extension To Meet Nasdaq Minimum Bid Price Requirement

EDEN PRAIRIE, Minn., Sept. 01, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (NASDAQ:CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, announced today receipt of written notification from the Nasdaq Stock Market that it has granted the company's request for an 180-day extension to regain compliance with Nasdaq's minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The company now has until February 24, 2021 to meet the requirement.

"We are pleased that Nasdaq granted our request for an extension," said John Erb, CEO of CHF Solutions. "We believe that we will regain compliance during the extended time period and continue to remain focused on driving revenue growth. We are happy that the medical community has embraced ultrafiltration therapy using the Aquadex(tm) System to treat pediatric patients, critically ill COVID-19 patients, and patients suffering from fluid overload due to heart failure and other critical care conditions."